Miltenyi Biotec GmbH
Originally published online as doi:10.1189/jlb.0408246 on February 13, 2009

Published online before print February 13, 2009
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
jlb.0408246v1
85/5/817    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, Y. H.
Right arrow Articles by Kwon, B. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, Y. H.
Right arrow Articles by Kwon, B. S.
(Journal of Leukocyte Biology. 2009;85:817-825.)
© 2009 Society for Leukocyte Biology

IFN-{gamma}-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo

Young H. Kim*, Beom K. Choi*, Woo J. Kang*, Kwang H. Kim*, Sang W. Kang{dagger}, Andrew L. Mellor{ddagger}, David H. Munn{ddagger} and Byoung S. Kwon*,§,1

* Division of Cell and Immunobiology and R&D Center for Cancer Therapeutics, National Cancer Center, Kyonggi-do, Korea;
{dagger} The Immunomodulation Research Center, University of Ulsan, Ulsan, Korea;
{ddagger} Medical College of Georgia, Immunotherapy Center, Augusta, Georgia, USA; and
§ Louisiana State University Eye Center, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA

1 Correspondence: Division of Cell and Immunobiology and R&D Center for Cancer Therapeutics, National Cancer Center, 809 Madu, Ilsan, Goyang, Kyounggi-do, Korea 411-769. E-mail: bskwon{at}ncc.re.kr

ABSTRACT

It has been reported that 4-1BB triggering in vivo selectively suppressed the recall response of staphylococcal enterotoxin A (SEA)-specific CD4+ T cells, in which CD8+ T-derived TGF-β was involved. Here, we have examined an alternative mechanism for the 4-1BB-mediated CD4+ T suppression, as the neutralization of TGF-β is only effective in rescuing the SEA-specific recall response at high cellular concentrations. We show that this selective suppression of CD4+ T cells by 4-1BB triggering in vivo is mediated mainly by induction of indoleamine 2,3-dioxygenase (IDO) in an IFN-{gamma}-dependent manner. SEA-specific CD4+ T responses were suppressed partly by TGF-β-expressing CD8+ T cells, particularly CD11c+CD8+ T cells, but strongly inhibited by dendritic cells (DCs) expressing IDO. IFN-{gamma} that increased IDO in DCs was produced primarily from CD11c+CD8+ T cells, which were expanded selectively by 4-1BB stimulation. CD4+, CD8+, and plasmacytoid DCs exerted a similar suppressive activity toward the SEA-specific CD4+ T cells. Neutralization of IFN-{gamma} or IDO activity in vivo largely reversed the 4-1BB-mediated CD4+ T suppression. Collectively, these data indicate that 4-1BB-dependent suppression of SEA-specific CD4+ T responses was mediated mainly by IFN-{gamma}-dependent IDO induction and partially by TGF-β.

Key Words: SEA • T cells • costimulation




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. Gu, R. B. Rowswell-Turner, M. O. Kilinc, and N. K. Egilmez
Central Role of IFN{gamma}-Indoleamine 2,3-Dioxygenase Axis in Regulation of Interleukin-12-Mediated Antitumor Immunity
Cancer Res., January 1, 2010; 70(1): 129 - 138.
[Abstract] [Full Text] [PDF]